News

Insulin changed the way we treat and manage diabetes. Chemotherapy has precipitously reduced the mortality rate of certain ...
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
Boston and London biotech company Vertex Pharmaceuticals is on a roll ... based treatment for type 1 diabetes that could potentially help people skip regular insulin injections by giving them healthy ...
Scientists have engineered bacteria to turn plastic waste into paracetamol, offering a sustainable new path for medicine and ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks to invest in now. On June 20, Vertex ...
Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...
How TIME and Statista Determined the World's Most Sustainable Companies of 2025 In the fight against climate change, companies are navigating ...
Wegovy is being made available in five dosing strengths with an easy-to-use pen device, which does away the use of syringes and can be self-administered at home ...
The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-lasting ...
Shares of Sana Biotechnology jumped after the company reported positive results for the latest study transplanting its UP421 cell therapy into a patient with type 1 diabetes. The stock was up 21% at ...
The evolution of diabetes technologies has led to the expansion of automated insulin delivery for type 2 diabetes, continuous ...